GlassScriptPhysician profile
Shadi Omidi
NPI 1366454548
$2,971.79
in general payments reported to CMS, 2019-2025
8 companies · $154 in 2025
The $154 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $22.07 · 2021: $234 · 2023: $1,735 · 2024: $460 · 2025: $154.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,363 · Consulting Fee: $975 · Gift: $10.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,363.40 |
| Consulting Fee | $975.00 |
| Gift | $10.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $975.00 | 2023 | |
| Intuitive Surgical, INC. | $940.25 | 2019-2024 | Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $606.28 | 2019-2024 | Lynparza |
| Mayne Pharma Commercial LLC | $153.70 | 2025 | |
| Astellas Pharma US INC | $124.99 | 2023 | Veozah |
| Hologic Sales and Service, LLC | $124.13 | 2024 | Novasure |
| Coopersurgical, INC. | $25.37 | 2024 | Paragard T 380a |
| Evofem Biosciences, INC. | $22.07 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shadi Omidi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.